Literature DB >> 2425804

A putative met-enkephalin releaser, kyotorphin enhances intracellular Ca2+ in the synaptosomes.

H Ueda, Y Yoshihara, H Takagi.   

Abstract

Kyotorphin (Tyr-Arg) at 1 to 100 microM increased the intracellular [Ca2+]i, determined with Quin-II in the slice and the entry of 45Ca2+ entry into synaptosomes of the lower brain stem of the rat. These effects were not antagonized by nifedipine nor verapamil. However, since this dipeptide caused no changes on the membrane potentials of the synaptosomes, measured with Rhodamine 6G, it is suggested that the kyotorphin-induced increase in the [Ca2+]i may be due not to effects on the voltage dependent Ca2+ channels and Na+-Ca2+ exchange mechanisms caused by the changes of the membrane potentials, but to the specific receptor (kyotorphin receptor)-mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425804     DOI: 10.1016/0006-291x(86)91164-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus.

Authors:  Kirsteen N Browning; Alexander E Kalyuzhny; R Alberto Travagli
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

2.  The pH-dependent conformational states of kyotorphin: a constant-pH molecular dynamics study.

Authors:  Miguel Machuqueiro; António M Baptista
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

3.  Inositol 1,4,5-trisphosphate-gated calcium transport through plasma membranes in nerve terminals.

Authors:  H Ueda; S Tamura; N Fukushima; T Katada; M Ui; M Satoh
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

4.  A novel method for the synthesis of kyotorphin, Tyr-Arg, and 3H-Tyr-Arg, catalyzed by tyrosyl-tRNA synthetase from Bacillus stearothermophilus.

Authors:  S Kitabatake; R Tsurutani; H Nakajima; K Tomita; Y Yoshihara; H Ueda; H Takagi; K Imahori
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

5.  Kinetically controlled enzyme-catalyzed synthesis of kyotorphin. An optimization study.

Authors:  P Clapés; G Valencia; F Reig; J M García Antón; J Mata
Journal:  Appl Biochem Biotechnol       Date:  1987-08       Impact factor: 2.926

6.  Inhibition of nociceptive responses after systemic administration of amidated kyotorphin.

Authors:  M M B Ribeiro; A Pinto; M Pinto; M Heras; I Martins; A Correia; E Bardaji; I Tavares; M Castanho
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

7.  Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model.

Authors:  Sónia Sá Santos; Sara M Santos; Antónia R T Pinto; Vasanthakumar G Ramu; Montserrat Heras; Eduard Bardaji; Isaura Tavares; Miguel A R B Castanho
Journal:  Front Aging Neurosci       Date:  2016-01-26       Impact factor: 5.750

Review 8.  Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives.

Authors:  Juliana Perazzo; Miguel A R B Castanho; Sónia Sá Santos
Journal:  Front Pharmacol       Date:  2017-01-12       Impact factor: 5.810

9.  The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer's Disease Pathophysiology.

Authors:  Rita F Belo; Margarida L F Martins; Liana Shvachiy; Tiago Costa-Coelho; Carolina de Almeida-Borlido; João Fonseca-Gomes; Vera Neves; Hugo Vicente Miranda; Tiago F Outeiro; Joana E Coelho; Sara Xapelli; Cláudia A Valente; Montserrat Heras; Eduard Bardaji; Miguel A R B Castanho; Maria José Diógenes; Ana M Sebastião
Journal:  Front Pharmacol       Date:  2020-07-09       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.